[ad_1]
WHO welcomes AstraZeneca’s decision to suspend coronavirus vaccine trials
The safety of volunteers participating in the trials is a priority, emphasizes the organization.
WHO has welcomed the suspension of trials of the AstraZeneca coronavirus vaccine, as the safety of volunteers is a priority. This was announced by the press service of the British-Swedish pharmaceutical company, Reuters reported on Wednesday 9 September.
WHO recommended “fully adhere to established testing protocols when testing all vaccines to ensure the safety of volunteers and the safety and efficacy of vaccines.”
“We are pleased to see that vaccine developers ensure the scientific validity of trials and follow the principles and rules of vaccine development,” the organization said.
In turn, the head of the British Ministry of Health Matt Hancock said that the British government will allow the massive use of the vaccine only “when there is strong confidence in its safety.”
“It’s not mandatory [значит, что вакцина будет одобрена позже, чем планировалось]… It all depends on the conclusions drawn after examining all the circumstances. There was already a hiatus in vaccine trials this summer, but then the problem was resolved and no problems arose, “Hancock said.
We will remember that before the leader of the race for the vaccine stopped conducting tests after the infection of a volunteer. For the first time, trials of a coronavirus vaccine were suspended. The reason was the COVID-19 infection of one of the volunteers who received the drug.
Already in circulation. What is known about the Russian vaccine.
News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet
